{
  "casebody": {
    "data": "<casebody firstpage=\"402\" lastpage=\"405\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties data-order=\"0\" data-type=\"parties\" id=\"b466-8\">In re PHARMACEUTICAL INDUSTRY AVERAGE WHOLESALE PRICE LITIGATION.</parties>\n<p data-order=\"1\" data-type=\"parties\" id=\"AVS\">This Document Relates to City of New York et al. v. Abbott Laboratories, et al. Civ. Action No. 04-cv-06054, et al. County of Nassau v. Abbott Laboratories, et al. Civ. Action No. 05-cv-10179.</p>\n<docketnumber data-order=\"2\" data-type=\"docketnumber\" id=\"b466-13\">MDL No. 1456.</docketnumber>\n<docketnumber data-order=\"3\" data-type=\"docketnumber\" id=\"AdH\">Civil Action No. 01-12257-PBS.</docketnumber>\n<court data-order=\"4\" data-type=\"court\" id=\"b466-15\">United States District Court, D. Massachusetts.</court>\n<decisiondate data-order=\"5\" data-type=\"decisiondate\" id=\"b466-17\">July 30, 2007.</decisiondate>\n<attorneys data-order=\"6\" data-type=\"attorneys\" id=\"b466-18\">Jeffrey B. Aaronson, Bell, Boyd <em>&amp; </em>Lloyd, Chicago, IL, for Baxter International, Inc.</attorneys>\n<attorneys data-order=\"7\" data-type=\"attorneys\" id=\"b466-19\">Marc E. Ackerman, Harris Beach LLP, Lara A. Berwanger, White &amp; Case LLP, Brian L. Bank, White <em>&amp; </em>Case LLP, New York, NY, for Sandoz, Inc.</attorneys>\n<attorneys data-order=\"8\" data-type=\"attorneys\" id=\"b466-20\">Joseph G. Adams, Snell &amp; Wilmer LLP, Phoenix, AZ, Jason E. Baranski, Morgan Lewis &amp; Bockius, LLP, Philadelphia, PA, for Pharmacia &amp; Upjohn, Inc.</attorneys>\n<attorneys data-order=\"9\" data-type=\"attorneys\" id=\"b466-21\">Pamela Zorn. Adams, Sherin and Lod-gen LLP, Boston, MA, for Gensia Sicor Pharmaceuticals, Inc.</attorneys>\n<attorneys data-order=\"10\" data-type=\"attorneys\" id=\"b466-22\">Kenneth W. Africano, Harter, Secrest Law Firm, Buffalo, NY, for Allergan Inc.</attorneys>\n<attorneys data-order=\"11\" data-type=\"attorneys\" id=\"b466-23\">Kevin N. Ainsworth, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., New York, NY, P. Ryan Beckett, Butler, Snow, O\u2019Mara, Stevens <em>&amp; </em>Cannada, Jackson, MS, for Eli Lilly and Company.</attorneys>\n<attorneys data-order=\"12\" data-type=\"attorneys\" id=\"b466-24\">Neil Alden, Curtis Bergen, Bowman and Brooke LLP, Phoenix, AZ, Jason Bruno, Dickstein Shapiro Morin <em>&amp; </em>Oshinsky LLP, <page-number citation-index=\"1\" label=\"403\">*403</page-number>Washington, DC, for Baxter Healthcare Corp.</attorneys>\n<attorneys data-order=\"13\" data-type=\"attorneys\" id=\"b467-4\">Brooks A. Ames, DLA Piper Rudnick Gray Cary U.S. LLP, Boston, MA, for Cardinal Health, Inc.</attorneys>\n<attorneys data-order=\"14\" data-type=\"attorneys\" id=\"b467-5\">C. Jarrett Anderson, Anderson LLC, Austin, TX, Gary L. Azorsky, Berger &amp; Montague, PC, Philadelphia, PA, James J. Breen, The Breen Law Firm, P.A., Alphar-etta, GA, for Ven-A-Care of the Florida Keys Inc.</attorneys>\n<attorneys data-order=\"15\" data-type=\"attorneys\" id=\"b467-6\">Anthony J. Anscombe, Melanie Matison Brown, Sedgwick Detert Moran <em>&amp; </em>Arnold, Chicago, IL, for Bristol-Myers Squibb Company.</attorneys>\n<attorneys data-order=\"16\" data-type=\"attorneys\" id=\"b467-7\">Justin S. Antonipillai, Arnold <em>&amp; </em>Porter, Washington, DC, Scott A. Birnbaum, Birn-baum <em>&amp; </em>Godkin, LLP, Boston, MA, for Ethex Corporation.</attorneys>\n<attorneys data-order=\"17\" data-type=\"attorneys\" id=\"b467-8\">Melissa Aoyagi, Davis Polk <em>&amp; </em>Wardwell, New York, NY, Michael P. Boudett, Jessica Vincent Barnett, Foley Hoag LLP, Boston, MA, for Astrazeneca Pharmaceuticals LP.</attorneys>\n<attorneys data-order=\"18\" data-type=\"attorneys\" id=\"b467-9\">Martin A. Aronson, Morrill <em>&amp; </em>Aronson, Phoenix, AZ, for Fujisawa Healthcare, Inc.</attorneys>\n<attorneys data-order=\"19\" data-type=\"attorneys\" id=\"b467-10\">Daniel F. Attridge, Kirkland <em>&amp; </em>Ellis, Washington, DC, for B. Braun Medical Inc.</attorneys>\n<attorneys data-order=\"20\" data-type=\"attorneys\" id=\"b467-11\">Megan M. Auchincloss, Morrison &amp; Foerster LLP, Denver, CO, for Purdue Pharma L.P.</attorneys>\n<attorneys data-order=\"21\" data-type=\"attorneys\" id=\"b467-12\">Pamela J. Auerbach, Kirkland &amp; Ellis LLP, Washington, DC, for Barr Laboratories, Inc.</attorneys>\n<attorneys data-order=\"22\" data-type=\"attorneys\" id=\"b467-13\">Jennifer Aurora, Sedgwick, Detert, Moran &amp; Arnold LLP, New York, NY, for Organon Pharmaceuticals USA, Inc.</attorneys>\n<attorneys data-order=\"23\" data-type=\"attorneys\" id=\"b467-14\">Violeta I. Balan, Mayer, Brown, Rowe &amp; Maw LLP, Chicago, IL, for Johnson <em>&amp; </em>Johnson.</attorneys>\n<attorneys data-order=\"24\" data-type=\"attorneys\" id=\"b467-15\">Mitchell J. Ba\u00f1as, Jr. Jaeckle Fleisch-mann &amp; Mugel LLP, Buffalo, NY, for Biogen Idee, Inc.</attorneys>\n<attorneys data-order=\"25\" data-type=\"attorneys\" id=\"b467-16\">Susan Hughes Banning, Hemenway <em>&amp; </em>Barnes, Boston, MA, for Neighborhood Health Plan, Inc.</attorneys>\n<attorneys data-order=\"26\" data-type=\"attorneys\" id=\"b467-17\">Anita Bapooji Ryan, Robert P. Blood, Goodwin Procter LLP, Boston, MA, for TAP Pharmaceutical Products, Inc.</attorneys>\n<attorneys data-order=\"27\" data-type=\"attorneys\" id=\"b467-18\">Scott A. Barbour, McName, Lochner, Titus &amp; Williams, Albany, NY, Patrick M. Bryan, Kirkland <em>&amp; </em>Ellis LLP, Washington, DC, for Ivax Corp.</attorneys>\n<attorneys data-order=\"28\" data-type=\"attorneys\" id=\"b467-19\">Steven F. Barley, Hogan &amp; Hartson, LLP, Baltimore, MD, Douglas S. Brooks, Kelly, Libby <em>&amp; </em>Hoopes, PC, Boston, MA, for Amgen Inc.</attorneys>\n<attorneys data-order=\"29\" data-type=\"attorneys\" id=\"b467-20\">Charles Barnhill, Miner, Barnhill &amp; Gal-land, Madison, WI, for Commonwealth of Kentucky.</attorneys>\n<attorneys data-order=\"30\" data-type=\"attorneys\" id=\"b467-21\">Christopher K. Barry-Smith, Office of the Attorney General, Boston, MA, for State of Massachusetts.</attorneys>\n<attorneys data-order=\"31\" data-type=\"attorneys\" id=\"b467-22\">S. Paul Battaglia, Bond, Schoeneck <em>&amp; </em>King PLLC, Syracuse, NY, for PAR Pharmaceutical, Inc.</attorneys>\n<attorneys data-order=\"32\" data-type=\"attorneys\" id=\"b467-23\">Jon Steven Baughman, Stacy D. Belf, Ropes &amp; Gray LLP, Washington, DC, Sheila L. Birnbaum, Skadden, Arps, Slate, Meagher <em>&amp; </em>Flom, New York, NY, Daniel J. Bennett, Ropes &amp; Gray LLP, Boston, MA, for Schering-Plough Corporation.</attorneys>\n<attorneys data-order=\"33\" data-type=\"attorneys\" id=\"b467-24\">Edwin Baum, Elise M. Bloom, Pros-kauer, Rose Law Firm, New York, NY, for Biovail Pharmaceuticals, Inc.</attorneys>\n<attorneys data-order=\"34\" data-type=\"attorneys\" id=\"b467-25\">Rebecca Bedwell-Coll, Mascone, Em-blidge <em>&amp; </em>Quadra, San Francisco, CA, for Constance Thompson.</attorneys>\n<attorneys data-order=\"35\" data-type=\"attorneys\" id=\"b467-26\">Terrianne Benedetto, Kline <em>&amp; </em>Specter, Philadelphia, PA, for International Union of Operating Engineers, Local No. 68 Welfare Fund.</attorneys>\n<attorneys data-order=\"36\" data-type=\"attorneys\" id=\"b468-3\"><page-number citation-index=\"1\" label=\"404\">*404</page-number>Elizabeth M. Bergen, Gibson, McAskill Law Firm, Buffalo, NY, Rex Blackburn, Blackburn &amp; Jones, Boise, ID, Nancy M. Bonnell, West Washington, Phoenix, AZ, for Abbott Laboratories, Inc.</attorneys>\n<attorneys data-order=\"37\" data-type=\"attorneys\" id=\"b468-4\">Mark A. Berman, Hartmann Doherty Rosa &amp; Berman, LLC, Hackensack, NJ, for Berlax Laboratories, Inc.</attorneys>\n<attorneys data-order=\"38\" data-type=\"attorneys\" id=\"b468-5\">Steve W. Berman, Hagens Berman So-bol Shapiro LLP, Seattle, WA, for Shirley Geller.</attorneys>\n<attorneys data-order=\"39\" data-type=\"attorneys\" id=\"b468-6\">David J. Bershad, Milberg Weiss Ber-shad Hynes <em>&amp; </em>Lerach LLP, New York, NY, Nicole Y. Brumsted, Lieff Cabraser Heimann &amp; Bernstein, LLP, Boston, MA, for Citizens for Consumer Justice.</attorneys>\n<attorneys data-order=\"40\" data-type=\"attorneys\" id=\"b468-7\">Adelina O. Berumen, California Department of Justice, Bureau of Medi-Cal Fraud, San Diego, CA, for State of California.</attorneys>\n<attorneys data-order=\"41\" data-type=\"attorneys\" id=\"b468-8\">Aimee E. Bierman, Kirkpatrick <em>&amp; </em>Lock-hart Preston Gates Ellis LLP, Boston,' MA, for Aventis Behring LLC.</attorneys>\n<attorneys data-order=\"42\" data-type=\"attorneys\" id=\"b468-9\">Brandon L. Bigelow, Bingham McCutchen LLP, Boston, MA, for Takeda Pharmaceuticals North America, Inc.</attorneys>\n<attorneys data-order=\"43\" data-type=\"attorneys\" id=\"b468-10\">Steven E. Bizar, Buchanan Ingersoll, P.C., Philadephia, PA, for Amerisource-Bergen Corporation.</attorneys>\n<attorneys data-order=\"44\" data-type=\"attorneys\" id=\"b468-11\">Sam B. Blair, Jr., Baker, Donelson, Bearman, Caldwell, &amp; Berkowitz, P.C., Memphis, TN, for Monarch Pharmaceuticals, Inc.</attorneys>\n<attorneys data-order=\"45\" data-type=\"attorneys\" id=\"b468-12\">Lynn M. Blake, Freidman, Hirsehen Law Firm, Albany, NY, for Eisai, Inc.</attorneys>\n<attorneys data-order=\"46\" data-type=\"attorneys\" id=\"b468-13\">Lynn M. Blake, Freidman, Hirsehen Law Firm, Albany, NY, for Genzyme Corporation.</attorneys>\n<attorneys data-order=\"47\" data-type=\"attorneys\" id=\"b468-14\">Jack B. Blumenfeld, Morris, Nichols, Arsht, <em>&amp; </em>Tunnell, Wilmington, DE, for Astrazeneca PLC.</attorneys>\n<attorneys data-order=\"48\" data-type=\"attorneys\" id=\"b468-15\">' Anthony Bolognese, Bolognese &amp; Associates, Philadelphia, PA, for Health Benefits Fund.</attorneys>\n<attorneys data-order=\"49\" data-type=\"attorneys\" id=\"b468-16\">Neville H. Boschert, Watkins, Ludlam, Winter &amp; Stennis, P.A., Jackson, MS, for Ivax Pharmaceuticals, Inc.</attorneys>\n<attorneys data-order=\"50\" data-type=\"attorneys\" id=\"b468-17\">Ali Bovingdon, Helena, MT, for State of Montana.</attorneys>\n<attorneys data-order=\"51\" data-type=\"attorneys\" id=\"b468-18\">Felix Lee Bowie, III, Davidson, Bowie &amp; Sims, PLLC, Jackson, MS, for Wyeth.</attorneys>\n<attorneys data-order=\"52\" data-type=\"attorneys\" id=\"b468-19\">George Ian Brandon, Sr., Squire Sanders &amp; Dempsey, LLP, Phoenix, AR, for Apothecon, Inc.</attorneys>\n<attorneys data-order=\"53\" data-type=\"attorneys\" id=\"b468-20\">Jeniphr Breckenridge, Hagens Berman Sobol Shapiro, LLP, Seattle, WA, for Plaintiffs.</attorneys>\n<attorneys data-order=\"54\" data-type=\"attorneys\" id=\"b468-21\">Thomas W. Breidenstein, Barrett &amp; Weber, Cincinnati, OH, for State of Ohio.</attorneys>\n<attorneys data-order=\"55\" data-type=\"attorneys\" id=\"b468-22\">Julie B. Brennan, Manchel <em>&amp; </em>Brennan, P.C., Newton, MA, for UnitedHealthcare, Inc. &amp; United Healthcare Insurance Company.</attorneys>\n<attorneys data-order=\"56\" data-type=\"attorneys\" id=\"b468-23\">Kenneth J. Brennan, John Anthony Bru-egger, SimmonsCooper LLC, East Alton, IL, for Edward West.</attorneys>\n<attorneys data-order=\"57\" data-type=\"attorneys\" id=\"b468-24\">Charlie Bridgmon, McCutchen, Balnton, Rhodes &amp; Johnson, Columbia, SC, for State of South Carolina.</attorneys>\n<attorneys data-order=\"58\" data-type=\"attorneys\" id=\"b468-25\">Ross B. Brooks, Milberg Weiss &amp; Ber-shad LLP, New York, NY, for County of Nassau.</attorneys>\n<attorneys data-order=\"59\" data-type=\"attorneys\" id=\"b468-26\">Raymond L. Brown, Brown, Buchanan &amp; Sessoms, PA, Pascagoula, MS, for As-trazenca LP.</attorneys>\n<attorneys data-order=\"60\" data-type=\"attorneys\" id=\"b468-27\">Bill L Bryant, Jr., Akerman Senterfitt, Tallahassee FL, for Boehringer Ingelheim International GMBH.</attorneys>\n<attorneys data-order=\"61\" data-type=\"attorneys\" id=\"b468-28\">Michael M. Buchman, Milbert, Weiss, Bershad, Hynes <em>&amp; </em>Lerach, LLP, New York, NY, for Colorado Progressive Coalition.</attorneys>\n<opinion data-order=\"62\" data-type=\"opinion\" id=\"x999-1\" type=\"majority\">\n<p id=\"b469-3\">\n<page-number citation-index=\"1\" label=\"405\">*405</page-number>\n<em>ORDER</em>\n</p>\n<author id=\"b469-4\">SARIS, District Judge.</author>\n<p id=\"b469-5\">Defendant pharmaceutical manufacturers have filed a renewed motion to dismiss plaintiff New York Counties\u2019 First Amended Consolidated Complaint (\u201cFACC\u201d), which plaintiffs amended in response to this Court\u2019s April 2, 2007 memorandum and order allowing-in-part and denying-in-part defendants\u2019 first motion to dismiss. <em>See City of New York v. Abbott Labs., </em>No. 01-cv-12257, 2007 WL 1051642 (D.Mass. April 2, 2007). The background to this motion was set out in detail in the Court\u2019s first Order, and will not be repeated here. After a hearing and review of the briefs, the Court <em>ALLOWS-IN-PART </em>and <em>DENIES-IN-PART </em>defendants\u2019 motion to dismiss.</p>\n<p id=\"b469-6\">1. The Court <em>ALLOWS </em>defendants\u2019 motion to dismiss all new drugs not listed in the initial Consolidated Complaint or Nassau County Complaint and attached exhibits. Defendants\u2019 motion is <em>DENIED </em>with respect to new NDC\u2019s and spreads pleaded in the FACC for the remaining drugs.</p>\n<p id=\"b469-7\">2. The Court <em>DENIES </em>defendants\u2019 motion to dismiss all Physician Administered Drugs. The plaintiffs have, at this stage of the proceedings, adequately alleged that the Counties reimbursed for these drugs on the basis of false or inflated Average Wholesale Prices submitted by defendants.</p>\n<p id=\"b469-8\">3. The Court <em>DENIES </em>defendants\u2019 motion to dismiss drugs subject to a Federal Upper Limit (\u201cFUL\u201d). Defendants argue that plaintiffs have not adequately alleged that defendants\u2019 submission of false or inflated published prices caused the Counties to overpay for drugs reimbursed through the state Medicaid program. <em>(See </em>Br. of the United States on the Federal Upper Limit, Docket No. 4413.) Under the terms of the applicable regulations, 42 C.F.R. \u00a7 447.332(a)(l)(ii), plaintiffs must allege that defendants submitted false or inflated <em>published </em>prices which, if truthful, would likely have affected the FUL. The plaintiffs and defendants shall each select five drugs subject to FUL reimbursement. Plaintiffs shall specifically make allegations with false published prices on those ten drugs. Discovery shall proceed on those FUL drugs only. The Court will address the plaintiffs\u2019 FUL claims as to those drugs on summary judgment with expert assistance and a more complete record.</p>\n<p id=\"b469-10\">4. The Court <em>DENIES </em>defendants\u2019 motion to dismiss all drugs for which plaintiffs have alleged a spread of 20-25%. However, discovery is stayed for all drugs with spreads lower than 30% until such time as the plaintiffs submit an expert affidavit providing a good faith basis for a 20-25% spread threshold.</p>\n<p id=\"b469-11\">5. Plaintiffs may not calculate the Actual Acquisition Cost of drugs at $0.01. Plaintiffs shall allege a weighted average, or typical, price for each drug calculated on a reasonable, good faith basis consistent with this Court\u2019s prior opinions. <em>See, e.g., City of New York v. Abbott Laboratories, </em>No. 01-cv-12257, 2007 WL 1051642, at 15, n. 8 (D.Mass.2007); Memorandum and Order, Docket No. 1482 (April 8, 2005). The Plaintiffs shall file an amended exhibit. I need not address the defendants\u2019 argument that plaintiffs are not using the appropriate classes of trade at this stage of the litigation.</p>\n</opinion>\n</casebody>\n",
    "status": "ok"
  }
}